Abstract: Described herein is a framework for deploying and updating applications (Apps). In accordance with one aspect, a source code of a hybrid application may be provided by a development environment running on a cloud server, in response to a user event. A deployment generator running on the cloud server may be automatically invoked to receive the source code of the hybrid application. The source code of the hybrid application may be further packaged to form a hybrid application package for deployment by the deployment generator. The hybrid application package may be deployed to a deployment service on the cloud server.

Abstract: Described herein is a technology to dynamically generate a user interface (UI). In one implementation, a data source is analyzed to determine field information of the data source. UI controls are mapped to fields of the data source based on the field information to generate UI control mapping information. Based on the field information and the UI control mapping information, a layout may be generated. The layout may then be presented for preview.

Abstract: Described herein is a technology to facilitate packaging and deployment of a hybrid application. In one implementation, one or more initial dependencies are identified from a configuration file associated with a hybrid application. Any issues associated with the initial dependencies may be resolved to generate one or more final dependencies. A package may be generated based on the one or more final dependencies and the hybrid application code. The package may then be deployed to a target device or device simulator.

Abstract: Techniques are presented herein to enable the storing of a base application. A plurality of program modules are stored with the base application, where the plurality of program modules comprise a first module and second module. User instructions are received to form a configuration file containing interaction rules, wherein the interaction rules define, for the base application, how the first module interacts with the second module to form a configured first module. The base application is then executed along with the configured first module on behalf of a user.

Abstract: Disclosed herein are system, method, and computer program product embodiments for implementing a data collection visualization facility. An embodiment operates by adding a visualization component to an application, to create a three-dimensional (3D) user interface and implementing a data adaptor associated with the visualization component. This embodiment further implements an event handler configured to function with the visualization component.

Abstract: Data model display and modification techniques are provided that can be executed on a wireless computing device. A data model display and modification technique includes wirelessly receiving a data model definition at a wireless communication device. A visual representation of the model definition is displayed on a display of the wireless device. User interactions with the visual representation of the model definition are recorded through the wireless device to alter the data model definition. The altered data model definition is stored, and transmitted to another device.

Abstract: Methods, systems, computer-readable media, and apparatuses for providing enhanced user interfaces are presented. In some embodiments, a computing device may generate a user interface that presents a selectable control element. Subsequently, the computing device may receive input selecting the control element. In response to receiving the input selecting the control element, the computing device may update the user interface to present a ring that includes at least one band of icons. In addition, the ring may have a first portion that is visible and a second portion, different from the first portion, that is hidden. In some instances, the computing device then may receive a selection of an icon included in the at least one band of icons. In response to receiving the selection of the icon, the computing device may update the user interface to hide the ring.

Abstract: Aspects of the present disclosure are directed towards responding to a touch gesture at a touch-enabled computing device. An interface control element may be presented at a first computing environment provided by a computing device. A touch gesture may be received at a touchscreen of the computing device, and it may be determined whether at least a portion of the touch gesture occurred at the interface control element. Based, at least in part, on whether at least a portion of the touch gesture occurred at the interface control element, a display of the first computing environment may be adjusted or information corresponding to the touch gesture may be transmitted to a second computing environment.

Abstract: Methods, systems, computer-readable media, and apparatuses for providing a native desktop using cloud-synchronized data are presented. In some embodiments, a desktop management service provided by at least one computing device may selectively store data from a remote desktop. Subsequently, the desktop management service may synchronize the stored data with a cloud-based data storage platform. Thereafter, the desktop management service may cause a native desktop to be presented on a client device using the synchronized data. In some arrangements, the extracted, analyzed, and/or selectively stored data may include one or more application shortcuts, one or more documents, one or more registry keys, one or more personalization settings, or one or more layout settings. Additionally or alternatively, the remote desktop may be associated with a first operating system, and the native desktop may be associated with a second operating system different from the first operating system.

Abstract: The invention belongs to the field of genetic engineering and biotechnology, and specifically discloses a design, preparation and pharmic application of a tumor-targeted TNF-related apoptosis-inducing ligand's variant. The tumor-targeted TNF-related apoptosis-inducing ligand's variant is generated by a fused protein which is consisted of the ligand of CD13, the connecting peptide and TNF-related apoptosis-inducing ligand's variant, and which is by the construction of coding gene of the variant according to the technology of genetic engineering and clone, soluble recombinant expression and ordinary separation and purification. The variant, produced by the method of preparation of the tumor-targeted TNF-related apoptosis-inducing ligand's variant, has favorable tumor-targeting characteristics and the significant enhancement of the anti-tumor effect.

Abstract: A method for transmitting data from a first device to a second device is provided. The method comprises steps of adding at least one NULL packet to the data in the first device to meet the alignment requirement of the second device and packing the data and the at least one NULL packet into a new packet; and transferring the new packet from the first device to the second device. And an apparatus for using the method is provided too.

Abstract: Connective tissue, including neo-tendons and ligaments, has been constructed using biodegradable synthetic scaffolds seeded with tenocytes. The scaffolds are preferably formed from biodegradable fibers formed of a polymer such as polyglycolic acid-polylactic acid copolymers, and seeded with cells isolated from autologous tendon or ligament by means of enzymatic digestion or direct seeding into tissue culture dishes from explants. The cell polymer constructs are then surgically transplanted to replace missing segments of functioning tendon or ligament.

Abstract: Provided is a fusion protein comprising a tumor necrosis factor related apoptosis inducing ligand (TRAIL), integrin ligands of ?V?3 and ?V?5 and a linking peptide. Also provided are the expression method and simple separation and purification process for the production of the fusion protein which is soluble and has high content of the polymer, and use of the fusion protein for the manufacturing of a medicament for the treatment of tumor. The fusion protein has good tumor tissue targeting property, significantly enhanced anti-tumor effect, which can also reduce the dose of the needed protein for the target treatment effect, improve the bioavailability, reduce the treatment cost, decrease and overcome the potential toxic and side effects of the tumor necrosis factor-related apoptosis inducing ligand.

Abstract: Connective tissue, including neo-tendons and ligaments, has been constructed using biodegradable synthetic scaffolds seeded with tenocytes. The scaffolds are preferably formed from biodegradable fibers formed of a polymer such as polyglycolic acid-polylactic acid copolymers, and seeded with cells isolated from autologous tendon or ligament by means of enzymatic digestion or direct seeding into tissue culture dishes from explants. The cell polymer constructs are then surgically transplanted to replace missing segments of functioning tendon or ligament.

Abstract: Connective tissue, including neo-tendons and ligaments, has been constructed using biodegradable synthetic scaffolds seeded with tenocytes. The scaffolds are preferably formed from biodegradable fibers formed of a polymer such as polyglycolic acid-polylactic acid copolymers, and seeded with cells isolated from autologous tendon or ligament by means of enzymatic digestion or direct seeding into tissue culture dishes from explants. The cell polymer constructs are then surgically transplanted to replace missing segments of functioning tendon or ligament.